Agenus Inc.

This person does not yet have a bio.

Content by Agenus Inc.

| 3 min read

ddn Cancer Research Portal Exclusive: Adjuvants--The Heroes of Immunotherapy

Dr. Garo Armen, Chairman and CEO of Agenus Inc., examines adjuvants and their potential in light of the growing interest and favorable market scene for cancer vaccines.

Articles

Page 1 of 1 - 1 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.

Miniaturizing patient-derived organoid screening for precision oncology

By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.

Articles

Miniaturizing patient-derived organoid screening for precision oncology

By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.

Articles